Thoracic Drainage Devices Market Report 2025 (Global Edition)

CURRENT SCENARIO OF THE THORACIC DRAINAGE DEVICES MARKET

Key factors driving the Thoracic Drainage Devices Market

• Increasing Prevalence of Respiratory and Thoracic illnesses among the population to drive the market growth

Thoracic drainage devices are in high demand due to the increasing prevalence of respiratory conditions such pleural effusion, pneumothorax, and chronic obstructive pulmonary disease (COPD). The rising prevalence of respiratory issues has increased the need for effective management and treatment strategies. In the US, respiratory illnesses are the leading cause of mortality and disability. In the US, approximately 16 million persons have COPD, and many more are not aware they have it. The Centers for Disease Control and Prevention (CDC) lists COPD as the sixth leading cause of death in the US. Thoracic drainage is often required for common respiratory issues such as pneumothorax and pleural effusion. Although these illnesses are common, there are differences in their prevalence. Pleural effusion, for example, has been linked to several medical disorders, including heart failure, pneumonia, and cancer.

Heart failure is becoming more commonplace globally, with an estimated 26 million cases and millions more undiagnosed cases. This can be attributed to a number of variables, including an aging population, an increase in cardiovascular risk factors, and improving survival rates for cardiovascular illnesses. Heart failure is a potentially fatal condition that affects both healthcare expenses and quality of life. 

According to the American Heart Association (AHA), approximately 550,000 new cases of congestive heart failure (CHF) are diagnosed in the United States each year. 
Further, as per the article published by the Heart and Stroke Foundation of Canada in February 2022, there are 750,000 people diagnosed with heart failure, which is increasing every year. 
(Source:https://www.ahajournals.org/doi/10.1161/CIR.0000000000001052)

Similarly, the prevalence of lung cancer has been increasing, necessitating surgical treatments involving the use of thoracic drainage devices. 

For example, the American Cancer Society estimates that lung cancer will be the top cause of cancer deaths in 2022, with 131,880 deaths. However, the national survival rate has increased by 21% to 25% over the last five years.
(Source:https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.html)

Postoperative drainage may be required for patients following lung resections or other thoracic procedures to manage fluid collection and prevent complications. Furthermore, due to variables such as air pollution, smoking, and aging populations, the prevalence of respiratory illnesses is predicted to rise further. 

As a result, the market trend for thoracic drainage devices is projected to change over the forecast period.

• The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market

The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.

For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. 
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828520/)

The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.

Also, The count of thoracic surgeries performed is increasing due to the rising incidence of lung cancer. ~80% of the total thoracic surgeries are performed for the treatment of different types of lung cancer. The major types of lung cancer include esophageal cancer and the cancers diagnosed in the pericardium, the chest wall, and mediastinum tumors. 

According to the World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. The number of thoracic surgeries performed globally has increased notably with the prevalence of the disease and a surge in its diagnosis. 

According to the research article “A brief overview of thoracic surgery in the US,” published in the Journal of Thoracic Disease in January 2022, nearly 530,000 general thoracic surgeries are performed annually in the US. 
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828520/)

The number of thoracic surgeries would continue to increase in the coming years with the rising incidence of lung cancer.

Factors affecting the growth of the market

• The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market

The main obstacle facing this business is the scarcity of qualified professionals. In order to perform thoracic drainage, a complex surgical technique requiring multidisciplinary cooperation, nurses are essential to the insertion and maintenance of chest tubes. But difficulties with chest tubes implanted by resident physicians are common, highlighting the need for additional training.
Healthcare workers grappling with the intricacies of chest drainage technology, including configuration, administration, and troubleshooting, have serious safety concerns. This dearth of knowledge prevents improved chest drainage systems from reaching their full potential and delays the implementation of novel ideas that could otherwise improve patient outcomes and care.

The difficulty of maintenance emphasizes the need for this constraint even more, since skilled staff are required for the regular maintenance, calibration, and prompt troubleshooting of chest drainage systems. In the absence of qualified healthcare personnel, equipment failure poses a serious risk that could disrupt patient care and make the problems being encountered by healthcare facilities worse.

Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons.

According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000.
(Source; https://www.rsna.org/news/2022/may/global-radiologist-shortage)

Opportunities

• The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth

There is potential for thoracic drainage device enhancement due to ongoing technological advancements. Businesses can gain a competitive edge by investing in research and development to produce technology that is more effective, user-friendly, and minimally intrusive. One possibility is the integration of digital health technologies for real-time drainage monitoring. Plans by governments to encourage digitization in the global healthcare sector are driving additional market growth. 

For example, during the 2022 budget session, the Government of India announced the Ayushman Bharat Digital Health Mission (ABDM) to create a digital health ecosystem. 
(Source: https://abdm.gov.in/DHIS)

Similarly, the French government announced in October 2021 that it will invest over USD 650 million to build its national digital health infrastructure. 
(Source:https://www.euractiv.com/section/health-consumers/news/french-government-to-invest-650-million-euros-in-digital-health/)

Thoracic drainage device manufacturers may differentiate themselves in the market by making investments in and effectively implementing digital health components. Better patient outcomes, fewer issues, and more effective healthcare delivery could arise from these developments. While technological advancements present benefits, companies also need to consider data security, regulatory compliance, and the requirement that healthcare professionals learn how to use new tools. If contemporary technology are to be successfully incorporated into thoracic drainage devices, these problems must be resolved. Thoracic drainage devices also have a bright future ahead of them thanks to the development of digital health technologies like artificial intelligence (AI) and the Internet of Things (IoT). 
Medical care that is more exact and individualized might result from real-time data collection, analysis, and intervention.
The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. 

For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).
(Source:https://www.globenewswire.com/news-release/2023/09/06/2738531/0/en/Merit-Medical-Launches-the-Aspira-Evacuated-Drainage-Bottle.html?f=22&fvtc=5&fvtv=44970062)

Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. 

Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.

How did COVID–19 Impact the Thoracic Drainage Devices Market?

As of August 2022, the World Health Organization (WHO) had received reports of about 585.0 million confirmed cases of COVID-19 worldwide, including over 6.4 million deaths. Thoracic drainage systems, on the other hand, have been shown to considerably reduce the huge spread of COVID-19. Individuals with COVID-19 have an increased chance of experiencing acute respiratory distress syndrome (ARDS), which requires the use of invasive mechanical ventilation. Moreover, barotrauma in COVID-19 patients frequently results in pneumothorax, necessitating the insertion of a chest tube (thoracostomy). 

Thoracic drainage devices have been shown to dramatically reduce the huge spread of COVID-19, according to medical studies. Individuals with COVID-19 are more likely to experience acute respiratory distress syndrome (ARDS), which necessitates the use of invasive mechanical ventilation.

Additionally, German Health Alliance (GHA) members, including B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Dräger, have witnessed a notable increase in the demand for their products, such as thoracic drainage system, from across the world since the beginning of 2020. 

For instance, ATMOS MedizinTechnik GmbH & Co. KG, an innovative medical device company, announced that production is running at full speed, as product groups such as drainage systems can save lives in the COVID-19 chaos. 
(Source:https://atmosmed.com/en/products-solutions/medical-suction-systems/atmos-electrical-suction/cardiothoracic-drainage/s201-thorax)

In December 2020, Medela LLC, a prominent supplier of breastfeeding accessories and medical vacuum technology, had announced that the filtration system of its ‘Thopaz+ Digital Chest Drainage and Monitoring System’ efficiently blocks passage of aerosolized viral particles, such as SARS-CoV-2. 
(Source:https://www.medelahealthcare.com/en-IN/solutions/chest-drainage/thopaz)

Therefore, respiratory diseases including COVID-19 are expected to open new opportunities in the global thoracic drainage devices market during the forecast period.

Post-pandemic - The comorbidities that raise the risk of death from infection with severe acute respiratory syndrome coronavirus 2 are frequently linked to surgical wounds and drains. To lower the danger in this susceptible population, suitable precautions are used when caring for patients with wounds. This is expected to have a significant impact on the market in COVID.  

As per the study published in April 2021, titled "Chest Tube Drainage in the Age of COVID-19", in patients with unknown COVID-19 status when chest tube placement is required on an urgent or emergent basis or in a patient with confirmed COVID-19-positive status, the procedure should be performed in a negative-pressure airborne precaution isolation room. 
(Source:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689312/#:~:text=Chest%20tubes%20are%20commonly%20placed,for%20the%20COVID%2D19%20patient.&text=Barotrauma%20caused%20by%20mechanical%20ventilation,commonly%20treated%20with%20tube%20thoracostomy.)

Therefore, due to the above-mentioned factors, the market is observed to have a significant impact during the pandemic. Even with the ongoing coronavirus pandemic, the healthcare and medical sector has seen a high rise globally.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Thoracic Drainage Devices Market is witnessing significant growth in the near future.

In 2023, the Pleural Drainage Catheters segment accounted for noticeable share of global Thoracic Drainage Devices Market and is projected to experience significant growth in the near future.

The Cardiac Surgery segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Teleflex Incorporated , Smiths Medical (ICU Medical Inc.) and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)